Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Orchid Pharma has informed the exchanges that the trading window for dealing in its securities will remain closed from April 1, 2026, until 48 hours after the declaration of its audited financial results (standalone and consolidated) for Q4 and the financial year ending March 31, 2026. This closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal insider trading code. The date of the board meeting to approve these results will be communicated separately. During this period, all designated persons and anyone with unpublished price-sensitive information are prohibited from trading in the company's shares.
This is a routine compliance filing and does not have a direct impact on the stock price. However, it signals that audited annual results are upcoming, which could be a key event for investors to watch for potential earnings-related price action.